These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32945146)

  • 1. Engineering of a Core-Shell Nanoplatform to Overcome Multidrug Resistance via ATP Deprivation.
    Liu G; Wang L; Liu J; Lu L; Mo D; Li K; Yang X; Zeng R; Zhang J; Liu P; Cai K
    Adv Healthc Mater; 2020 Oct; 9(20):e2000432. PubMed ID: 32945146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
    Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
    Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance.
    Liu J; Zhao L; Shi L; Yuan Y; Fu D; Ye Z; Li Q; Deng Y; Liu X; Lv Q; Cheng Y; Xu Y; Jiang X; Wang G; Wang L; Wang Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54343-54355. PubMed ID: 32959645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy.
    Jiang W; Chen L; Guo X; Cheng C; Luo Y; Wang J; Wang J; Liu Y; Cao Y; Li P; Wang Z; Ran H; Zhou Z; Ren J
    Theranostics; 2022; 12(6):2987-3006. PubMed ID: 35401832
    [No Abstract]   [Full Text] [Related]  

  • 6. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
    Wei G; Yang G; Wei B; Wang Y; Zhou S
    Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion.
    Liu Y; Zhang L; Ma Z; Tian L; Liu Y; Liu Y; Chen Q; Li Y; Ma E
    Free Radic Res; 2019 Jul; 53(7):758-767. PubMed ID: 31170853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
    Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
    J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance.
    Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R
    Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoresponsive Nanovehicle for Two Independent Wavelength Light-Triggered Sequential Release of P-gp shRNA and Doxorubicin To Optimize and Enhance Synergistic Therapy of Multidrug-Resistant Cancer.
    Wu M; Lin X; Tan X; Li J; Wei Z; Zhang D; Zheng Y; Zheng AX; Zhao B; Zeng Y; Liu X; Liu J
    ACS Appl Mater Interfaces; 2018 Jun; 10(23):19416-19427. PubMed ID: 29771490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hyaluronic acid modified cuprous metal-organic complex for reversing multidrug resistance via redox dyshomeostasis.
    Wan Y; Chen Z; Wang Y; Zhao W; Pei Z; Pu L; Lv Y; Li J; Li J; Pei Y
    Carbohydr Polym; 2023 Jul; 311():120762. PubMed ID: 37028879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts.
    Li C; Xue HG; Feng LJ; Wang ML; Wang P; Gai XD
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4437-4445. PubMed ID: 29077148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-Switchable Yolk-Mesoporous Shell UCNPs@MgSiO
    Li S; Song X; Zhu W; Chen Y; Zhu R; Wang L; Chen X; Song J; Yang H
    ACS Appl Mater Interfaces; 2020 Jul; 12(27):30066-30076. PubMed ID: 32393026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.